Wang, P., Han, X., Bi, H., Li, E., Ren, K., Aydemir, I., Cai, W., Soleimani, L., Ji, P. (2025). Plek2 as a novel downstream effector of p53: Targeting Plek2 ameliorates disease progression in p53-deficient myeloid malignancies. Blood. https://doi.org/10.1182/blood-2025-216